| 1. |
Sakaguchi, S., Sakaguchi, N., Shimizu, J., et al. (2001) Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity and transplantation tolerance. Immunol. Rev.
182, 18–32.
|
| |
| 2. |
Maloy, K. J. and Powrie, F. (2001) Regulatory T cells in the control of immune pathology. Nat. Immunol.
2, 816–822.
|
| |
| 3. |
Shevach, E. M. (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol.
2, 389–400.
|
| |
| 4. |
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995) Immunologic self-tolerance maintained by activated
T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune
diseases. J. Immunol.
155, 1151–1164.
|
| |
| 5. |
Asano, M., Toda, M., Sakaguchi, N., and Sakaguchi, S. (1996) Autoimmune disease as a consequence of developmental abnormality
of a T cell subpopulation. J. Exp. Med.
184, 387–396.
|
| |
| 6. |
Suri-Payer, E., Amar, A. Z., Thornton, A. M., and Shevach, E. M. (1998) CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory
cells. J. Immunol.
160, 1212–1218.
|
| |
| 7. |
Shimizu, J., Yamazaki, S., and Sakaguchi, S. (1999) Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol.
163, 5211–5218.
|
| |
| 8. |
Sutmuller, R. P., van Duivenvoorde, L. M., van Elsas, A., et al. (2001) Synergism of cytotoxic T lymphocyte-associated antigen
4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte
responses. J. Exp. Med.
194, 823–832.
|
| |
| 9. |
Itoh, M., Takahashi, T., Sakaguchi, N., et al. (1999) Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol.
162, 5317–5326.
|
| |
| 10. |
Takahashi, T., Kuniyasu, Y., Toda, M., et al. (1998) Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol.
10, 1969–1980.
|
| |
| 11. |
Thornton, A. M. and Shevach, E. M. (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med.
188, 287–296.
|
| |
| 12. |
Thornton, A. M. and Shevach, E. M. (2000) Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol.
164, 183–190.
|
| |
| 13. |
Salomon, B., Lenschow, D. J., Rhee, L., et al. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity
12, 431–440.
|
| |
| 14. |
Takahashi, T., Tagami, T., Yamazaki, S., et al. (2000) Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med.
192, 303–310.
|
| |
| 15. |
Read, S., Malmstrom, V., and Powrie, F. (2000) Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the
function of CD25+CD4+ regulatory cells that control intestinal inflammation. J. Exp. Med.
192, 295–302.
|
| |
| 16. |
Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., and Sakaguchi, S. (2002) Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol.
3, 135–142.
|
| |
| 17. |
McHugh, R. S., Whitters, M. J., Piccirillo, C. A., et al. (2002) CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor.
Immunity
16, 311–323.
|
| |
| 18. |
Lehmann, J., Huehn, J., de la Rosa, M., et al. (2002) Expression of the integrin alpha Ebeta 7 identifies unique subsets of
CD25+ as well as CD25− regulatory T cells. Proc. Natl. Acad. Sci. USA
99, 13,031–13,036.
|
| |
| 19. |
Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M., and Demengeot, J. (2003) Regulatory T cells selectively
express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med.
197, 403–411.
|
| |
| 20. |
Hori, S., Nomura, T., and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3.
Science
299, 1057–1061.
|
| |
| 21. |
Khattri, R., Cox, T., Yasayko, S. A., and Ramsdell, F. (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol.
4, 337–342.
|
| |
| 22. |
Fontenot, J. D., Gavin, M. A., and Rudensky, A. Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol.
4, 330–336.
|
| |
| 23. |
Walker, L. S., Chodos, A., Eggena, M., Dooms, H., and Abbas, A. K. (2003) Antigen-dependent proliferation of CD4+CD25+ regulatory T cells in vivo. J. Exp. Med.
198, 249–258.
|
| |
| 24. |
Klein, L., Khazaie, K., and von Boehmer, H. (2003) In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA
100, 8886–8891.
|
| |
| 25. |
Yamazaki, S., Iyoda, T., Tarbell, K., et al. (2003) Direct expansion of functional CD25+CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med.
198, 235–247.
|
| |
| 26. |
Annacker, O., Pimenta-Araujo, R., Burlen-Defranoux, O., Barbosa, T. C., Cumano, A., and Bandeira, A. (2001) CD25+CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol.
166, 3008–3018.
|
| |
| 27. |
Gavin, M. A., Clarke, S. R., Negrou, E., Gallegos, A., and Rudensky, A. (2002) Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nat. Immunol.
3, 33–41.
|
| |
| 28. |
Fisson, S., Darrasse-Jeze, G., Litvinova, E., et al. (2003) Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J. Exp. Med.
198, 737–746.
|
| |
| 29. |
Sakaguchi, S., Hori, S., Fukui, Y., Sasazuki, T., Sakaguchi, N., and Takahashi, T. (2003) Thymic generation and selection
of CD25+CD4+ regulatory T cells: implications of their broad repertoire and high self-reactivity for the maintenance of immunological
self-tolerance. Novartis Found. Symp.
252, 6–16.
|
| |
| 30. |
Nishimura, E., Sakihama, T., Setoguchi, R., Tanaka, K., and Sakaguchi, S. (2004) Induction of antigen-specific immunologic
tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+ CD25+CD4+ regulatory T cells. Int. Immunol.
16, 1189–1201.
|
| |
| 31. |
Godfrey, W. R., Ge, Y. G., Spoden, D. J., et al. (2004) In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly
inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood
104, 453–461.
|
| |
| 32. |
Hoffmann, P., Eder, R., Kunz-Schughart, L. A., Andreesen, R., and Edinger, M. (2004) Large-scale in vitro expansion of polyclonal
human CD4(+)CD25high regulatory T cells. Blood
104, 895–903.
|
| |
| 33. |
Hoffmann, P., Ermann, J., Edinger, M., Fathman, C. G., and Strober, S. (2002) Donor-type CD4(+)CD25(+) regulatory T cells
suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med.
196, 389–399.
|
| |
| 34. |
Cohen, J. L., Trenado, A., Vasey, D., Klatzmann, D., and Salomon, B. L. (2002) CD4(+)CD25(+) immunoregulatory T Cells: new
therapeutics for graft-versus-host disease. J. Exp. Med.
196, 401–406.
|
| |